ÂÜÀòÂÒÂ×

Yasmin Khan is a seasoned professional in program and portfolio management with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Program and Portfolio Management Leader at Excision BioTherapeutics since September 2021, Yasmin has a robust background that includes a decade-long tenure at Regeneron Pharmaceuticals, Inc. as Director of Program Management, and prior roles at Johns Hopkins University as Sr. Program Manager/Clinical Trial Leader, managing clinical trials in Oncology, and at Yale University as Clinical Research Associate II focusing on Neuroimmunological trials. Educational qualifications include a Master of Public Health in Epidemiology from the University of South Carolina, a Master of Science in Biotechnology from the University of Mumbai, and a Bachelor of Science in Life Sciences from St Xaviers College.